Sotatercept Use in a Patient with Pulmonary Arterial Hypertension Undergoing Lung Transplantation
Pulmonary arterial hypertension (PAH) is one of the common indications for lung transplantation. Sotatercept is a new medication with a novel mechanism of action and was recently approved for the treatment of PAH. Sotatercept is associated with significant adverse effects including thrombocytopenia...
Salvato in:
| Autori principali: | , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2025-05-01
|
| Serie: | JHLT Open |
| Soggetti: | |
| Accesso online: | http://www.sciencedirect.com/science/article/pii/S2950133425000084 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|